Literature DB >> 10738038

Irradiation of platelet components: inhibition of lymphocyte proliferation assessed by limiting-dilution analysis.

N L Luban1, D Drothler, G Moroff, R Quinones.   

Abstract

BACKGROUND: Using a limiting-dilution analysis (LDA) assay that measures clonigenic T cells, it has been demonstrated that, with 2500 cGy, there is no T-cell growth in red cell components irradiated in blood bags. In the current study, the LDA assay was used to investigate the effect of gamma radiation on the proliferative capacity of T cells in plateletpheresis components. STUDY DESIGN AND METHODS: Platelets were collected by using an apheresis instrument and settings that provided sufficient mononuclear cells for the LDA assay. Platelet components (n = 8) were irradiated in 1-L plastic bags 24 hours after collection with 500, 1500, and 2500 cGy of gamma radiation in a stepwise manner. Mononuclear cells were isolated after each irradiation dose by the use of ficoll-hypaque. A density separation medium was used to reduce the platelet numbers. T cells were enumerated by fluorescence-activated cell sorter and functionally assessed by LDA assay, which quantified T cells proliferating in the presence of polyclonal stimuli and cytokines. The frequency of T-cell growth (f) was visually scored after 4 weeks of incubation at 37 degrees C. Data were calculated as f(experimental)/f(control) and expressed as log(10) reduction.
RESULTS: The T-cell content of the mononuclear cell population was 17 +/- 10.5 percent, which was unaltered by irradiation. After 500-cGy irradiation, functional T cells were reduced by 2.09 log(10). Irradiation with 1500 cGy resulted in a 3. 96 log(10) reduction, but viable clonable T cells were detected in all experiments. With 2500-cGy irradiation, no T-cell growth was detected; this represented a greater than 4.86 log(10) reduction.
CONCLUSION: As the dose of gamma radiation delivered to plateletpheresis components increased, the number of residual functional T cells decreased exponentially. Irradiation with 2500 cGy inactivates T cells in apheresis platelets, as measured by an LDA assay.

Mesh:

Substances:

Year:  2000        PMID: 10738038     DOI: 10.1046/j.1537-2995.2000.40030348.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  To study the effects of gamma irradiation on single donor apheresis platelet units by measurement of cellular counts, functional indicators and a panel of biochemical parameters, in order to assess pre-transfusion platelet quantity and quality during the shelf life of the product.

Authors:  R S Mallhi; A K Biswas; J Philip; T Chatterjee
Journal:  Med J Armed Forces India       Date:  2015-12-18

2.  Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.

Authors:  Rachael P Jackman; John W Heitman; Susanne Marschner; Raymond P Goodrich; Philip J Norris
Journal:  Transfusion       Date:  2009-08-04       Impact factor: 3.157

3.  Implementation of a new cost efficacy method for blood irradiation using a non dedicated device.

Authors:  Paola Pinnarò; Antonella Soriani; Daniela D'Alessio; Carolina Giordano; Maria Laura Foddai; Valentina Pinzi; Lidia Strigari
Journal:  J Exp Clin Cancer Res       Date:  2011-01-12

4.  How do we … integrate pathogen reduced platelets into our hospital blood bank inventory?

Authors:  Sara Rutter; Edward L Snyder
Journal:  Transfusion       Date:  2019-03-18       Impact factor: 3.157

5.  Prevention of transfusion-associated graft-versus-host disease by irradiation: technical aspect of a new ferrous sulphate dosimetric system.

Authors:  Lucas Sacchini Del Lama; Evamberto Garcia de Góes; Paulo César Dias Petchevist; Edson Lara Moretto; José Carlos Borges; Dimas Tadeu Covas; Adelaide de Almeida
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

6.  Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.

Authors:  Steve Kleinman; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2015-08-25       Impact factor: 3.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.